Ethyl (2R,4R)-4-Methyl-2-Piperidinecarboxylate CAS 74892-82-3 Argatroban Intermediate Maʻemaʻe Kiʻekiʻe
Mea Hoʻolako Mea Hana Argatroban Nā Kūwaena Pili:
Ethyl (2R,4R)-4-Methyl-2-Piperidinecarboxylate CAS 74892-82-3
N-Nitro-1,2,3,4-tetradehydro Argatroban Ethyl Ester CAS 74874-09-2
3-Methyl-8-Quinolinesulphonyl Chloride CAS 74863-82-4
Argatroban Monohydrate CAS 141396-28-3
Argatroban Anhydrous CAS 74863-84-6
| Inoa Kimia | Ethyl (2R,4R)-4-Methyl-2-Piperidinecarboxylate |
| Nā huaʻōlelo like | Ethyl (2R,4R)-4-Methylpipecolate;(2R,4R)-4-Methyl-2-Piperidinecarboxylate;(2R,4R)-Ethyl 4-Methylpiperidine-2-Carboxylate;Ethyl-(2R,4R)-4-Methylpiperidine-2-Carboxylate |
| Helu CAS | 74892-82-3 |
| Helu CAT | RF-PI267 |
| Kūlana Kūʻai | Ma ka waihona, ʻoi aku ka nui o ka hana a hiki i nā tona |
| ʻĀpana Molekala | C9H17NO2 |
| Kaumaha Molecular | 171.24 |
| Kūlana Hoʻouna | Hoʻouna ʻia ma lalo o ka wela ambient |
| Brand | ʻO Ruifu Chemical |
| 'ikamu | Nā kikoʻī |
| Ka nana aku | Akaka i ka wai melemele māmā |
| Diastereoisomer | ≤1.0% |
| Maʻemaʻe / Kaʻina Hanana | ≥98.0% (GC) |
| Metala Kaumaha | ≤20ppm |
| Kūlana hoʻāʻo | ʻOihana Kūlana |
| Hoʻohana | ʻO Argatroban Intermediate (CAS 74863-84-6) |
Pūʻolo: ʻO ka'ōmole, Barrel, 25kg / Barrel, aiʻole e like me ka makemake o ka mea kūʻai.
Kūlana mālama:E mālama i loko o nā pahu i hoʻopaʻa ʻia ma kahi maloʻo a maloʻo;Palekana mai ka malamalama, ka ma'ū a me ka pest infestation.
ʻO Shanghai Ruifu Chemical Co., Ltd. ka mea hana nui a me ka mea hoʻolako o Ethyl (2R, 4R) -4-Methyl-2-Piperidinecarboxylate (CAS: 74892-82-3) me ke kūlana kiʻekiʻe.ʻO Ethyl (2R,4R) -4-Methyl-2-Piperidinecarboxylate (CAS: 74892-82-3) he mea waena maʻamau i ka synthesis o Argatroban Monohydrate (CAS 141396-28-3) a i ʻole Argatroban (CAS 74863-8). ).
ʻO Argatroban Monohydrate kahi mea paʻa thrombin kikoʻī, ʻo ia ka non-heparin anticoagulant, pale i ka hoʻokumu ʻana o ka thrombi.ʻO Argatroban kahi anticoagulant kahi mole liʻiliʻi liʻiliʻi thrombin inhibitor.I ka makahiki 2000, ua laikini ʻia ka argatroban e ka Food and Drug Administration (FDA) no ka prophylaxis a i ʻole ka mālama ʻana i ka thrombosis i nā maʻi me ka thrombocytopenia (HIT).
